ID   COLO 832
AC   CVCL_2000
SY   COLO-832; Colo 832; COLO832; Colorado 832
DR   CLO; CLO_0002565
DR   CLDB; cl857
DR   ECACC; 93051124
DR   Wikidata; Q54814160
RX   PubMed=7780963;
CC   Population: Caucasian.
CC   Discontinued: ECACC; 93051124; probable.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
RX   PubMed=7780963;
RA   Easty D.J., Guthrie B.A., Maung K., Farr C.J., Lindberg R.A.,
RA   Toso R.J., Herlyn M., Bennett D.C.;
RT   "Protein B61 as a new growth factor: expression of B61 and
RT   up-regulation of its receptor epithelial cell kinase during melanoma
RT   progression.";
RL   Cancer Res. 55:2528-2532(1995).
//